Meta-analysis of exome sequencing data identifies new recurrently mutated driver genes for prostate cancer. Comparison of primary and metastatic tumors further identifies genomic markers for advanced prostate cancer that may inform risk stratification.
- Joshua Armenia
- Stephanie A. M. Wankowicz
- Eliezer M. Van Allen